Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease (Q34834837)

4 August 2017

1 reference

title

Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease (English)

1 reference

4 August 2017

0 references

Joanna Q Hudson

1 reference

4 August 2017

Roya M Sameri

series ordinal

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

issue

9 Pt 2

1 reference

4 August 2017

page(s)

141S-149S

1 reference

Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Anemia: an early complication of chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Quality of life in predialytic uremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

How should anaemia be managed in pre-dialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Development and characterization of novel erythropoiesis stimulating protein (NESP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Obesity as a risk factor in renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.14.141S.33397

10.1592/PHCO.22.14.141S.33397

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference